What are the guidelines for managing diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Managing Diabetes

The management of diabetes requires a comprehensive, patient-centered approach that includes a multidisciplinary team, individualized glycemic targets, lifestyle modifications, appropriate pharmacologic therapy, and regular screening for complications to optimize morbidity, mortality, and quality of life outcomes. 1

Initial Evaluation and Assessment

  • A complete medical evaluation should be performed at diagnosis to classify diabetes, detect complications, review previous treatment, and establish a management plan 1, 2
  • Laboratory tests should include HbA1c, fasting glucose, lipid profile, kidney function tests, and urine albumin-to-creatinine ratio 1
  • Screen for autoimmune conditions in type 1 diabetes (thyroid dysfunction, celiac disease) 2
  • Assess for comorbidities including obesity, hypertension, dyslipidemia, and existing microvascular complications 1

Team-Based Care Approach

  • Diabetes care should be managed by a multidisciplinary team including physicians, nurse practitioners, nurses, dietitians, pharmacists, and mental health professionals 1, 2
  • The management plan should be written with input from the patient, family, physician, and other healthcare team members 2, 1
  • Implement shared decision-making to improve treatment adherence, patient satisfaction, and clinical outcomes 2

Glycemic Targets and Monitoring

  • Set individualized HbA1c targets based on patient's age, comorbidities, risk of hypoglycemia, and life expectancy 1
  • The proportion of people with diabetes who achieve recommended A1C, blood pressure, and LDL cholesterol levels has fluctuated over the years, with only 23% meeting all three targets while avoiding smoking 2
  • Regular HbA1c testing (typically every 3-6 months) is recommended to assess long-term glycemic control 1, 3

Lifestyle Management

Nutrition

  • Implement medical nutrition therapy with individualized meal planning 1, 2
  • No ideal percentage of calories from carbohydrate, protein, and fat exists for all people with diabetes; macronutrient distribution should be based on individualized assessment 2
  • Various eating patterns can be effective, including Mediterranean-style, DASH, plant-based, lower-fat, and lower-carbohydrate patterns 2

Physical Activity

  • Encourage 30-60 minutes of moderate aerobic activity daily, at least 5 days per week 2
  • Consider adding resistance training twice weekly 2
  • Physical activity can reduce HbA1c by 0.4-1.0% and improve cardiovascular risk factors 4

Weight Management

  • For overweight/obese patients, prescribe high-intensity diet, physical activity, and behavioral therapy designed to achieve ≥5% weight loss 1
  • Recommend 500-750 kcal/day energy deficit to promote weight loss 1

Diabetes Self-Management Education and Support (DSMES)

  • Provide DSMES to all patients at diagnosis and at critical points throughout their care 5
  • Education should focus on helping patients make informed self-management choices rather than simply providing information 5
  • Include essential content on hypoglycemia/hyperglycemia recognition and treatment, medication administration, blood glucose monitoring, and nutritional management 5

Pharmacologic Therapy

Initial Therapy

  • Initiate pharmacologic therapy at diagnosis of type 2 diabetes, in addition to lifestyle therapy 1
  • For metabolically stable patients (HbA1c <8.5% and asymptomatic), metformin is the initial treatment of choice if renal function is adequate (>30 ml/min/1.73 m²) 1, 6
  • For patients with marked hyperglycemia (blood glucose ≥250 mg/dL, HbA1c ≥8.5%) who are symptomatic, consider initiating basal insulin while starting metformin 1

Medication Selection

  • For patients with cardiovascular or kidney comorbidities or at high cardiovascular risk, consider early treatment with SGLT2 inhibitors and/or GLP-1 receptor agonists 4
  • Thiazolidinediones like pioglitazone can be used as an adjunct to diet and exercise to improve glycemic control 3
  • Adjust treatment based on clinical outcomes, patient preferences, and development of complications 1

Cardiovascular Risk Factor Management

  • Blood pressure control is recommended (target <140/90 mmHg or <130/80 mmHg for individuals with chronic kidney disease or diabetes) 2
  • Initiate blood pressure medication as tolerated, treating initially with beta blockers and/or ACE inhibitors 2
  • Manage lipid abnormalities aggressively, particularly in patients with cardiovascular disease 2
  • Recommend smoking cessation and avoidance of environmental tobacco smoke 2

Complication Screening and Prevention

  • Conduct regular screening for microvascular complications, including annual comprehensive eye examination, screening for diabetic kidney disease, and comprehensive foot examination 1
  • Screen for and treat modifiable cardiovascular risk factors 1
  • Provide all age-appropriate vaccinations 1

Common Pitfalls and Considerations

  • Patient adherence to complex regimens may be challenging; simplify when possible and address barriers to care 1
  • Consider social determinants of health that may impact a patient's ability to follow treatment recommendations 1
  • Metformin can cause an unpleasant metallic taste when starting the medication, but this typically resolves quickly 6
  • Monitor for hypoglycemia, especially when using insulin or insulin secretagogues 6
  • Monitor liver function before and periodically during treatment with thiazolidinediones like pioglitazone 3

References

Guideline

Comprehensive Management of Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Comprehensive Approach to Diabetes Education and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.